Luxist Web Search

  1. Ads

    related to: sellas life sciences stock forecast this week today live

Search results

  1. Results From The WOW.Com Content Network
  2. Shareholders Are Raving About How The SELLAS Life Sciences ...

    www.aol.com/news/shareholders-raving-sellas-life...

    For premium support please call: 800-290-4726 more ways to reach us

  3. SELLAS Life Sciences Stock Plunges After $25M Capital ... - AOL

    www.aol.com/news/sellas-life-sciences-stock...

    GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwide outside of Greater China (mainland China, Hong ...

  4. Galena Biopharma - Wikipedia

    en.wikipedia.org/wiki/Galena_Biopharma

    Number of employees. 60 (March 2014) Website. www.sellaslifesciences.com. Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, [1][2] and in 2015 moved to San Ramon, California. [3]

  5. Is SELLAS Life Sciences Group, Inc. (SLS) A Good Stock ... - AOL

    www.aol.com/news/sellas-life-sciences-group-inc...

    Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...

  6. Live Science - Wikipedia

    en.wikipedia.org/wiki/Live_Science

    Live Science is a science news website. It publishes stories in a wide variety of topics such as Space, Animals, Health, Archaeology, Human behavior and Planet Earth. It also has a Forum section for open discussions and a Reference section with links to other sites. Their mission is "make the wonders of science and the world around us relevant ...

  7. Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In ...

    www.aol.com/news/sellas-ovarian-cancer-candidate...

    SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...

  1. Ads

    related to: sellas life sciences stock forecast this week today live